Correction: Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome.
Where this comes from
- Record sourced from PubMed, PMID 39937752.
- Also identified by DOI 10.1371/journal.pone.0319527 and PMC identifier 11819519.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0302298.].